« Back
Home /
LY3023414

LY3023414

Item no.	TMO-T6883-50mg
Manufacturer	TargetMol
CASRN	1386874-06-1
Amount	50mg
Category	Oncology Reagents & Chemicals Molecules By Organ Skin Cancer
Type	Molecules
Specific against	other
Citations	1. Zou Y., Targeting PI3K-AKT-mTOR by LY3023414 inhibits human skin squamous cell carcinoma cell growth in vitro and in vivo. Biochem Biophys Res Commun. 2017 Aug 19;490(2):385-392.
Smiles	O=c1n(c2c(c3cc(c4cc(C(O)(C)C)cnc4)ccc3nc2)n1C[C@H](C)OC)C
ECLASS 10.1	32169090
ECLASS 11.0	32169090
UNSPSC	12000000
Alias	GTPL8918 , LY3023414
Available
Short Description	LY3023414 is an oral ATP competitive inhibitor of the class I PI3K isoforms, DNA-PK, and mTOR. LY3023414 has been used in trials studying the treatment of Neoplasm, Solid Tumor, COLON CANCER, BREAST CANCER, and Advanced Cancer, among others.
Shipping	cool pack
Storage	-20°
Target names or alias	GTPL8918 , LY3023414
Molecular Weight	406, 48
Pathway	PI3K/Akt/mTOR signaling\|\|\|DNA Damage/DNA Repair\|\|\|Autophagy
Target	PI3K\|\|\|Autophagy\|\|\|mTOR\|\|\|DNA-PK

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 50mg

available

Delivery expected until 9/6/2024

Express Delivery: Save 3 days

Compare

Add to wishlist

Recommend by mail